Association of the Pri- Rs531564 Polymorphism with Cancer Risk: A Meta-analysis

Overview

Journal Mol Clin Oncol

Specialty Oncology

Date 2015 Jul 15

PMID 26171202

Citations 6

Authors

Cheng Fang

Hui Zeng

Anling Li

Xianqun Xu

Xinghua Long

Affiliations

Soon will be listed here.

Abstract

Cg/cc: OR, 0.54; 95% CI, 0.36-0.81). Furthermore, in the subgroup analysis by cancer sites, a statistical association was identified between the rs531564 polymorphism and a decreased esophageal squamous cell carcinoma (ESCC) risk (G vs. C: OR, 0.87; 95% CI, 0.77-0.98; GG vs. CC: OR, 0.54; 95% CI, 0.34-0.84). These findings suggested that the genetic variant of rs531564 may have a potential value in decreasing cancer risk, particularly in ESCC patients.

Citing Articles

A Single Variant in Pri-miRNA-155 Associated with Susceptibility to Hereditary Breast Cancer Promotes Aggressiveness in Breast Cancer Cells.

Landeros N, Gonzalez-Hormazabal P, Perez-Moreno P, Tapia J, Jara L Int J Mol Sci. 2022; 23(23).

PMID: 36499743 PMC: 9735695. DOI: 10.3390/ijms232315418.

Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis.

Zhou Z, Lv J, Wang J, Yu H, Lu H, Yuan B Dis Markers. 2019; 2019:1654780.

PMID: 31885731 PMC: 6893269. DOI: 10.1155/2019/1654780.

Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta-analysis and genome-wide association studies.

Tian J, Liu C, Liu G, Zuo C, Chen H Cancer Med. 2019; 8(3):1289-1305.

PMID: 30793520 PMC: 6434199. DOI: 10.1002/cam4.1972.

Association between miR-124-1 rs531564 polymorphism and risk of cancer: An updated meta-analysis of case-control studies.

Moazeni-Roodi A, Hashemi M EXCLI J. 2018; 17:608-619.

PMID: 30108465 PMC: 6088220. DOI: 10.17179/excli2018-1419.

Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases.

Ciccacci C, Politi C, Biancone L, Latini A, Novelli G, Calabrese E Mol Diagn Ther. 2016; 21(1):107-114.

PMID: 27718165 DOI: 10.1007/s40291-016-0240-1.

References

Zhou Y, Du W, Chen G, Ruan J, Xu S, Zhou F . Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol. 2012; 138(6):939-45. DOI: 10.1007/s00432-012-1164-8. View

Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J . Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2008; 30(1):79-84. DOI: 10.1002/humu.20837. View

Xu W, Xu J, Liu S, Chen B, Wang X, Li Y . Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One. 2011; 6(5):e20471. PMC: 3102728. DOI: 10.1371/journal.pone.0020471. View

Ruan K, Fang X, Ouyang G . MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009; 285(2):116-26. DOI: 10.1016/j.canlet.2009.04.031. View

Jin Y, Lee C . Single Nucleotide Polymorphisms Associated with MicroRNA Regulation. Biomolecules. 2014; 3(2):287-302. PMC: 4030849. DOI: 10.3390/biom3020287. View

Xiong X, Cheng J, Liu X, Tang S, Luo X . [Correlation analysis between miR-124 rs531564 polymorphisms and susceptibility to cervical cancer]. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34(2):210-3. View

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

Qi L, Hu Y, Zhan Y, Wang J, Wang B, Xia H . A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population. Neurosci Lett. 2012; 515(1):1-6. DOI: 10.1016/j.neulet.2012.02.061. View

Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos D, Stathopoulos E . MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle. 2011; 10(3):507-17. DOI: 10.4161/cc.10.3.14754. View

10.

Wang F, Sun G, Zou Y, Li Y, Hao L, Pan F . Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS One. 2012; 7(9):e45042. PMC: 3438197. DOI: 10.1371/journal.pone.0045042. View

11.

Shi X, Xue L, Ma A, Tepper C, Gandour-Edwards R, Kung H . Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. 2012; 32(35):4130-8. PMC: 4111479. DOI: 10.1038/onc.2012.425. View

12.

Yin J, Wang X, Zheng L, Shi Y, Wang L, Shao A . Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One. 2013; 8(11):e80570. PMC: 3832359. DOI: 10.1371/journal.pone.0080570. View

13.

Silber J, Lim D, Petritsch C, Persson A, Maunakea A, Yu M . miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008; 6:14. PMC: 2443372. DOI: 10.1186/1741-7015-6-14. View

14.

Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J . miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2009; 31(5):766-76. DOI: 10.1093/carcin/bgp250. View

15.

Chen T, Li Z, Yan J, Yang X, Salminen W . MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis. 2011; 27(1):59-66. DOI: 10.1093/mutage/ger060. View

16.

Ma F, Zhang P, Lin D, Yu D, Yuan P, Wang J . There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population. PLoS One. 2013; 8(3):e60195. PMC: 3608627. DOI: 10.1371/journal.pone.0060195. View

17.

DerSimonian R, Kacker R . Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2006; 28(2):105-14. DOI: 10.1016/j.cct.2006.04.004. View

18.

Barbarotto E, Schmittgen T, Calin G . MicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2007; 122(5):969-77. DOI: 10.1002/ijc.23343. View

19.

Nicoloso M, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M . Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010; 70(7):2789-98. PMC: 2853025. DOI: 10.1158/0008-5472.CAN-09-3541. View

20.

Yang H, Dinney C, Ye Y, Zhu Y, Grossman H, Wu X . Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 2008; 68(7):2530-7. DOI: 10.1158/0008-5472.CAN-07-5991. View